Adrenal Glands pp 131-142 | Cite as

Primary Adrenocortical Carcinoma

  • Charles A.G. Proye
  • François N. Pattou
  • Jonathan Armstrong


Positron Emission Tomography Adrenal Tumor Adrenal Mass None None Adrenocortical Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Icard P, Chapuis Y, Andreasssian B, et al. (1992) Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 112:972PubMedGoogle Scholar
  2. 2.
    Venkatesh S, Hickey RC, Sellin RV, et al. (1989) Adrenal cortical carcinoma. Cancer 64:765PubMedGoogle Scholar
  3. 3.
    Copeland PM (1984) The incidentally discovered adrenal mass. Ann Surg 199:116PubMedGoogle Scholar
  4. 4.
    van Heerden JA, Grant CS, Weaver AL (1993) Primary carcinoma of the adrenal cortex: An institutional surgical perspective. Acta Chir Aust 25:216Google Scholar
  5. 5.
    Proye C, Jafari Manjili M, Combemale F, et al. (1998) Experience gained from operation of 103 adrenal incidentalomas. Langenbecks Arch Surg 383:330–333CrossRefPubMedGoogle Scholar
  6. 6.
    Mcleod MK (1993) Adrenal incidentaloma. Acta Chir Aust 25:202Google Scholar
  7. 7.
    Chapuis Y, Icard P (1994) Cortico-surrénalomes malins: In: Chapuis Y, Peix JL (eds) Chirurgie des glandes surrénales. Arnette, Paris, p 61Google Scholar
  8. 8.
    Ludwig, Nierderle B, Roka R, et al.(1993) Isolieter primärer Aldosterismus bei Nebennierenkarzinom. Kasuitik und Leteraturübersicht. Acta Chir Aust 25:212Google Scholar
  9. 9.
    Proye C, Fossati P, Ben Soussan D, et al. Syndrome d’Anderson avec pseudo-hyperparathyroïdisme. Chirurgie (Paris) 111:364Google Scholar
  10. 10.
    Gicquel C, Lelond-Rrancillard M, Bertagna W, et al. (1994) Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol 40:465Google Scholar
  11. 11.
    Icard P, Louvel A, Chapuis Y (1992) Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 16:453CrossRefGoogle Scholar
  12. 12.
    Gicquel C, Bertagna X, Schneid H, et al. (1994) Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Metab 78:1444CrossRefGoogle Scholar
  13. 13.
    Yashiro T, Hara H, Fulton NC, et al. (1994) Point mutations of ras-genes in human adrenal cortical tumors: Absence in adrenocortical hyperplasia. World J Surg 18:455PubMedGoogle Scholar
  14. 14.
    Aupetit-Faisant B, Tabarin A, Battaglia C, et al. (1991) Incohérence de la voie des minéralocorticoïdes dans les carcinomes surrénaliens: Un signe de malignité? Ann Endocrinol (Paris) 52:149Google Scholar
  15. 15.
    Khafagi FA, Gross MD, Shapiro B, et al. (1991) Clinical significance of the large adrenal mass. Br J Surg 78:828PubMedGoogle Scholar
  16. 16.
    Peix JL (1994) Incidentalomes. In: Chapuis Y, Peix JL (eds) Chirurgie des glandes surrénales. Arnette, Paris, p 115Google Scholar
  17. 17.
    Gross MD, Shapiro B, Francis IR, et al. (1994) Scintigraphic evaluation of clinically silent adrenal mass. J Nucl Med 35:1145PubMedGoogle Scholar
  18. 18.
    Pasieka JL, McLeod MK, Thompson NW, et al. (1992) Adrenal scintigraphy of well-differentiated (functioning) adrenocortical carcinomas: Potential surgical pitfalls. Surgery 112:884PubMedGoogle Scholar
  19. 19.
    Rubello D, Ruffini V, Casara D, et al. (2002) Clinical role of positron emission tomography (PET) in endocrine tumors. Panminerva Med 44:185–196PubMedGoogle Scholar
  20. 20.
    Yun M, Kim W, Alnafisi N, et al. (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795–9PubMedGoogle Scholar
  21. 21.
    Becherer A, Vierhapper H, Potzi C, et al. (2001) FDP-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 16:289–95CrossRefPubMedGoogle Scholar
  22. 22.
    Weiss LM (1995) Comparative histological study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163–169Google Scholar
  23. 23.
    Aubert S, Wacrenier A, Leroy X, et al. (2002) Weiss system revisited: a clinicopathological and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26:1612–9CrossRefPubMedGoogle Scholar
  24. 24.
    Hosaka Y, Rainwater LM, Grant CS, et al. (1987) Adrenal carcinoma: Nuclear DNA study by flow cytometry. Surgery 102:1027PubMedGoogle Scholar
  25. 25.
    Weiss LM, Medeiors LJ, Vickery AL (1989) Pathological features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202PubMedGoogle Scholar
  26. 26.
    Vargas MP, Vargas HI, Kleiner DE, et al. (1997) Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB. Am J Surg Pathol 21:556–562CrossRefPubMedGoogle Scholar
  27. 27.
    Javadpour N (1987) Principles and management of adrenal cancer. Springer-Verlag, BerlinGoogle Scholar
  28. 28.
    Icard P, Louvel A, Chapuis Y (1990) Fréquence et valeur pronostique de l’extension ganglionnaire et rénale dans les corticosurrénalomes. Lyon Chir 86:151Google Scholar
  29. 29.
    Ritchey M, Kinard R, Novicki DE (1987) Adrenal tumors: Involvement of the inferior vena cava. J Urol 138:1134PubMedGoogle Scholar
  30. 30.
    Benoit G, Darteville P (1990) Ablation d’un thrombus cave retro-hépatique sans abord thoracique. Ann Urol (Paris) 24:384Google Scholar
  31. 31.
    Pommier RF, Brennan MF (1992) An eleven year experience with adrenal carcinoma. Surgery 112:963PubMedGoogle Scholar
  32. 32.
    Decker RA, Kuehner ME (1991) Adrenocortical carcinoma. Am Surg 57:502PubMedGoogle Scholar
  33. 33.
    Decker RA, Elson P, Hogan TF, et al. (1991) Eastern cooperation oncology group study 1879: Mitotan and Adriamycin in patient with advanced adrenocortical carcinoma. Surgery 111:1006Google Scholar
  34. 34.
    Lack EE, Travis WD, Oertel JE (1990) Adrenal cortical neoplasms. In: Lack EE (ed) Pathology of the adrenal glands. Churchill Livingstone, Edinburgh, p 115Google Scholar
  35. 35.
    Luton JP, Cerdas S, Billaud L, et al. (1990) Adrenocortical carcinoma: Clinical features, prognostic factors and therapeutic results in 105 patients from a single centre (1967-1987). N Eng J Med 322:1195Google Scholar
  36. 36.
    Henley DJ, van Heerden JA, Grant CS, et al. (1983) Adrenal cortical carcinoma: A continuing challenge. Surgery 94:926PubMedGoogle Scholar
  37. 37.
    Cohn K, Gottesman L, Brennan MF (1986) Adrenocortical carcinoma. Surgery 100:1170PubMedGoogle Scholar
  38. 38.
    Icard P, Goudet P, Charpenay C, et al. (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French association of endocrine surgeons study group. World J Surg 25:891–897CrossRefPubMedGoogle Scholar
  39. 39.
    Boven E, Vermoken JB, Slotten HV, et al. (1984) Complete response of metastasized adrenal cortical carcinoma with o.p’-DDD: Case report and literature review. Cancer 53:26PubMedGoogle Scholar
  40. 40.
    Abraham J, Bakke S, Rutt A, et al. (2002) A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion of doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Cancer 94:2333–43PubMedGoogle Scholar
  41. 41.
    Percarpio B, Knowlton AH (1976) Radiation therapy of adrenal cortical carcinoma. Acta Radiother 15:288Google Scholar
  42. 42.
    Scott HW Jr (1987) Experience with adrenocortical neoplasms in children. Am Surg 53:117PubMedGoogle Scholar
  43. 43.
    MacFarlane D (1958) Cancer of the adrenal cortex: the natural history, prognosis, and treatment in a study of 55 cases. Ann R Coll Surg Engl 23:155PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Charles A.G. Proye
  • François N. Pattou
  • Jonathan Armstrong

There are no affiliations available

Personalised recommendations